Status:
UNKNOWN
Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Hemophilia A
Hemophilia B
Eligibility:
All Genders
18+ years
Brief Summary
Hemophilia is a constitutional coagulation disorder responsible for a hemorrhagic phenotype in patients from an early age. Hemarthrosis is one of the most frequent complications in hemophiliacs and le...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Hemophilia A or B adult patient, with or without arthropathy
- Heathly control
- Exclusion criteria:
- Antiinflammatory drug use
- immunosuppressive treatment or condition
Exclusion
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05187936
Start Date
October 1 2021
End Date
December 31 2022
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295